The current price is in 11,92$, Kalvista Pharmaceuticals Inc, with address at 55 CAMBRIDGE PARKWAY SUITE 901 EAST, CAMBRIDGE, Massachusetts, 2142, United States, is a publicly traded company and its visible heads at the moment are Benjamin L. Palleiko (Chief Financial & Business Officer), Edward P. Feener (Chief Scientific Officer), Paul K. Audhya (Chief Medical Officer), T. Andrew Crockett (Chief Executive Officer & Director). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 11,70$ - 12,06$, with a percentage difference of 11,88$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.